Member Info for Jurado

Could you explain what it means if "MMs use your shares"? And why would you want to stop it?

Looking at Scancell's sp charts, it seemed to take around a week after the announcement of their grant before their price started to rise. It then doubled in fairly quick time, but it's worth bearing in mind that if we do get a grant but don't get the immediate reaction many of you appear to think we will, it still might come along a bit later.

I wonder how many of the people complaining about the lack of fanfare over the launch are marketing people or otherwise part of the intended audience for our services? The impression I'm getting is that this £3m market cap company should have booked out the ad breaks in Coronation Street. Few if any customers will come across an rns (we'd issued one on 7 October covering the launch anyway). I wouldn't really expect to see any other specific promotional activity around the launch - if it did reach me it would be wasted effort anyway wouldn't it because I ain't buying what they are selling. I'm trusting they have strategies to reach those who are though.

Not overly dramatic but we are now at 52 week high, so hopefully there's more to come. We've lot of promising companies but I have always thought that Oxford Nanopore was key to ever getting a return here.

I'm going reasonably pessimistic - 0.42.
GLA

From memory I bought in here nearly 10 years back when the price was around 20p and we had visions of the desert turning into one big market garden as Arab princelings commissioned forward osmosis plants from Cairo to Basra. Well given how that turned out I'd more or less given up, but this is a welcome cat out of the bag. Still some way from getting money back but at least in with a shout now and, more importantly really, the new company may play an important role in fighting the virus.

As Fumbs explained, far more shares have been issued now - but also like many early-stage companies, the share price is based on future hope, not actual performance. It got to 30p because people got a bit carried away with enthusiasm as it moved to launch phase. When the hard reality of making a profit kicks in a people realise it will take years to make a profit, and then a couple of years more, and then there's difficulty with supply, and then there's problems with financing and more dilution, then there's a cyber attack, and then there's a virus and then they have to drop the price hugely to get a placing filled...well enthusiasm is harder to find. I bought in at 13p many years ago, but have averaged down as the price fell from 30p because I still feel the business could do really well if it can make it over the line to profitability.

I think you may be confusing megawatts and megawatt hours. The Gloucester site website states they produce 14.5 megawatts, as you say we will - eventually - produce 220.

"MWG have spent £20m on their technology and IP alone and therefore SP should be circa 4p without any revenue." Is that how it works then?

TRX? Well firstly I wish I'd sold at 30p! The recent narrative has been "rosy future if we can just eke out the money til profitability" - but breakeven has been staying resolutely on the horizon as we walk towards it. Sales have expanded but not really at the pace I was expecting - can't say I'm massively confident but did take a small amount more at the placing which I will keep in the hope I can sell next year to defray the loss on shares bought years ago.

Lots to read here and I'll give the report a close study later. I should probably let it go but I'm still dwelling on the Avacta sale. The company says it was all in line with their policies which they are sticking to even though 'With hindsight, the timing of this exit proved to be unfortunate, with the company's share price increasing significantly following announcement of COVID-19-related developments.'

But fortunately it was not all bad news. At the end of document we find out directors' personal holdings in portfolio companies and fortunately it appears Alan Aubrey decided to hold on to his 191,334 Avacta shares, gaining him an extra 200 grand since beginning of April . So that was nice. Interestingly he bought an extra 10 million in Tissue Regenix - presumably in that heavily discounted placing in May - I have reasons for hoping his instincts are correct on that one too.

Interesting to note that having sold up here last month, IP Group has taken a stake with unlisted UK hydrogen fuel cell company Bramble Energy, which likes to talk of itself as the world's most scalable fuel cell company. It claims it can look at gigawatts because its cells can be produced at any Printed Circuit Board factory. Very early days at Bramble, which fits IP's strategy, but I wonder if there's any story behind all this - and whether there are, or could be in the future, any links between Bramble and CWR. One to look out for possibly.

I hope it's the next ARM - I 12 -bagged there. Along with Greggs one of very few successes.

Yes IP sold their shares. That is what they do - they fund early stage University spinouts - then sell up at a profit to fund more early stage investments. The 'placing' had nothing directly to do with CWR, it was IP selling their rather large share.

That was one of ours - I think we let it fly away about five years ago, so we can claim moral credit if it helps solves the Covid crisis, even if someone else reaps the financial benefits.

Whenever there is a reminder that any project, not just this one, is not going to make you rich in the next month or so, a company's sp seems to drop. To my mind there's nothing to worry about here - indeed broadly positive decisions. Doubt whether this fall will last long, so this is a buying opportunity.

I think most LTH lost faith in this being a company that wanted to return money to share holders some time ago. It does a good job at supporting new businesses (and of course in paying themselves) but not in investor returns. Of course it is just about possible that the current shift towards cashing in a few more chips will actually result in a dividend, or a hint of dividends to come that will boost the SP, though disasters such as AVCT won't help. I've only got a small pot here so I'm hanging on just in case.

IP's strategy is not to hold into maturity but to see a company from University spinout through to profitability and than take the profit and reinvest. They've been under pressure to crystalise a bit more profit and recently made a huge error (well they say an error, some people have suspicions) when they sold off their 15 per cent Avacta holding two days before the price rocketed with a Covid-related breakthrough. So selling CWR at this stage does seem to fit - they are guaranteed a big profit, even if most of us think it could be a lot bigger in a few years time.

So I put my question about Avacta to the AGM and AA addressed it. Basically he fessed up to simply getting it wrong. We had 15 per cent of the company but no one on the board. We had a policy of realising more gains and there was liquidity in the market so we sold and the two days later... I paraphrase a little but 'in hindsight we got it wrong...we can't get it right every time...sorry for getting it wrong on this occasion...but it is listed so you could always buy your own shares'. Not sure we've got the whole story there but what can we do?

Wow. If all it takes for a 50 per cent rise is for the CEO to announce the company is undervalued I wish a few more in my portfolio would do it. ??